Allergist Expert Onsite At The FDA Advisory Committee Meeting On LABAs
On Wednesday, March 10 and Thursday, March 11, the FDA is convening an Advisory Committee meeting on the clinical trial design for long acting beta-2 adrenergic agonists (LABA’s). Bob Lanier, M.D…
(more...)